Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOPINAVIR for Maternal exposure timing unspecified: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where LOPINAVIR was used for Maternal exposure timing unspecified.

Most Reported Side Effects for LOPINAVIR

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 244 19.7% 73 44
Exposure during pregnancy 184 14.8% 22 26
Virologic failure 170 13.7% 7 3
Drug resistance 134 10.8% 9 3
Off label use 133 10.7% 41 70
Lipodystrophy acquired 126 10.1% 1 1
Premature baby 107 8.6% 28 13
Diplopia 89 7.2% 0 4
Treatment failure 89 7.2% 1 1
Premature delivery 88 7.1% 1 5
Eyelid ptosis 87 7.0% 0 0
Mitochondrial toxicity 82 6.6% 0 0
Viral mutation identified 76 6.1% 0 0
Progressive external ophthalmoplegia 73 5.9% 0 0
Pathogen resistance 54 4.4% 0 3

Other Indications for LOPINAVIR

Hiv infection (706) Covid-19 (108) Prophylaxis against hiv infection (96) Product used for unknown indication (68) Antiretroviral therapy (47) Antiviral treatment (34) Foetal exposure during pregnancy (16) Hepatitis viral (10) Perinatal hiv infection (10) Covid-19 pneumonia (9)

Other Drugs Used for Maternal exposure timing unspecified

VALPROATE (1,477) ADALIMUMAB (1,280) NATALIZUMAB (492) RITONAVIR (486) EMTRICITABINE\TENOFOVIR DISOPROXIL (333) LOPINAVIR\RITONAVIR (278) DIVALPROEX (254) INTERFERON BETA-1A (245) DIMETHYL (212) ATAZANAVIR (169)

Related Pages

LOPINAVIR Full Profile All Maternal exposure timing unspecified Drugs LOPINAVIR Demographics LOPINAVIR Timeline